Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Veolia Water Technologies & Solutions, formerly known as Suez Water Technologies & Solutions, is a global leader in water recovery, treatment, and process solutions. The company provides critical infrastructure for the life sciences sector, including ultrapure water systems and wastewater management technologies essential for pharmaceutical manufacturing. A key part of its portfolio is the Sievers line of analytical instruments, which are the industry standard for Total Organic Carbon (TOC) monitoring in pharmaceutical quality control. Their solutions support compliance with global pharmacopeia standards for Water-for-Injection (WFI) and purified water. Following the 2022 acquisition of Suez by Veolia, the division has integrated advanced digital tools to optimize water cycles in drug manufacturing and clinical settings. The company serves thousands of customers in the biotech, pharmaceutical, and healthcare industries, ensuring process reliability and environmental sustainability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SUEZ Water Technologies.